Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Mirum Pharmaceuticals, Inc. (MIRM) had Return on Investments of -3.74% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$521.31M |
|
$-23.36M |
|
$100.24M |
|
$421.07M |
|
$543.45M |
|
$-22.14M |
|
$0.71M |
|
$-21.43M |
|
$-21.43M |
|
$-23.36M |
|
$-23.36M |
|
$-23.36M |
|
$-23.36M |
|
$-22.14M |
|
$3.85M |
|
50.20M |
|
50.20M |
|
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$549.68M |
|
$1.86M |
|
$293.13M |
|
$842.81M |
|
$205.80M |
|
$309.80M |
|
$322.32M |
|
$528.12M |
|
$314.69M |
|
$53.77M |
|
$314.69M |
|
51.90M |
|
| Cash Flow Statement Financials | |
$55.83M |
|
$-23.95M |
|
$40.14M |
|
$222.93M |
|
$298.17M |
|
$75.24M |
|
$71.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.67 |
|
-- |
|
-- |
|
0.50 |
|
0.98 |
|
80.77% |
|
-4.25% |
|
-4.25% |
|
0.74% |
|
-4.11% |
|
-4.48% |
|
$54.87M |
|
-- |
|
-- |
|
-- |
|
0.62 |
|
4.03 |
|
4.23 |
|
86.35 |
|
-7.42% |
|
-43.45% |
|
-2.77% |
|
|
Return on Investments |
-3.74% |
$6.06 |
|
$1.09 |
|
$1.11 |
|